BBPWM
DNA icon

Blue Bell Private Wealth Management’s Ginkgo Bioworks DNA Stock Holding History

Blue Bell Private Wealth Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-7
Closed -$69 – 731
2024
Q4 		$69 Hold
7
– – ﹤0.01% 672
2024
Q3 		$57 Sell
7
-1
-13% -$10 ﹤0.01% 683
2024
Q2 		$100 Hold
8
– – ﹤0.01% 709
2024
Q1 		$348 Hold
8
– – ﹤0.01% 711
2023
Q4 		$507 Hold
8
– – ﹤0.01% 702
2023
Q3 		$543 Hold
8
– – ﹤0.01% 658
2023
Q2 		$558 Hold
8
– – ﹤0.01% 670
2023
Q1 		$399 Hold
8
– – ﹤0.01% 651
2022
Q4 		$507 Hold
8
– – ﹤0.01% 672
2022
Q3 		$1K Hold
8
– – ﹤0.01% 660
2022
Q2 		$1K Hold
8
– – ﹤0.01% 708
2022
Q1 		$1K Hold
8
– – ﹤0.01% 770
2021
Q4 		$2K Buy
+8
New +$3.8K ﹤0.01% 667

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return